Literature DB >> 25001023

Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia.

Michal Kovo1, Letizia Schreiber2, Osnat Elyashiv3, Avi Ben-Haroush4, Golan Abraham3, Jacob Bar3.   

Abstract

OBJECTIVE: To compare pregnancy outcome and placental pathology in pregnancies complicated by fetal growth restriction (FGR) with and without preeclampsia.
METHODS: Labor, fetal/neonatal outcome, and placental pathology parameters from neonates with a birth weight below the 10 th percentile (FGR), born between 24 and 42 weeks of gestation, were reviewed. Results were compared between pregnancies complicated with preeclampsia (hypertensive FGR [H-FGR]) to those without preeclampsia (normotensive FGR [N-FGR]). Composite neonatal outcome, defined as 1 or more of early complication (respiratory distress, necrotizing enterocolitis, sepsis, transfusion, ventilation, seizure, hypoxic-ischemic encephalopathy, phototherapy, or death), Apgar score ≤ 7 at 5 minutes, and days of hospitalization, were compared between the groups. Placental lesions, classified as lesions related to maternal vascular supply, lesions consistent with fetal thrombo-occlusive disease and inflammatory lesions, maternal inflammatory response, and fetal inflammatory response, were also compared.
RESULTS: Women in the H-FGR group (n = 72) were older, with higher body mass index (BMI) and higher rate of preterm labor (<34 weeks) than in the N-FGR group (n = 270), P < .001 for all. Composite neonatal outcome was worse in the H-FGR than in the N-FGR group, 50% versus 15.5%, P < .001. Higher rate of maternal placental vascular lesions was detected in H-FGR compared with N-FGR, 82% versus 57.7%, P < .001. Using a stepwise logistic regression model, maternal BMI (1.13 odds ratio [OR], confidence interval [CI] 1.035-1.227, P = .006) and neonatal birth weight (0.996 OR, CI 0.995-0.998, P < .001) were independently associated with worse neonatal outcome.
CONCLUSION: Worse neonatal outcome and more maternal placental vascular lesions in pregnancy complicated by FGR with preeclampsia versus FGR without preeclampsia suggest different pathophysiology in these entities.
© The Author(s) 2014.

Entities:  

Keywords:  fetal growth restriction; histopathology; placenta; preeclampsia

Mesh:

Year:  2014        PMID: 25001023     DOI: 10.1177/1933719114542024

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  8 in total

1.  Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study.

Authors:  Steven J Korzeniewski; Roberto Romero; Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Chong Jai Kim; Yeon Mee Kim; Jung-Sun Kim; Bo Hyun Yoon; Sonia S Hassan; Lami Yeo
Journal:  Am J Obstet Gynecol       Date:  2015-12-11       Impact factor: 8.661

2.  Hypertensive disease, preterm birth, fetal growth restriction and chronic inflammatory disorders of the placenta: experiences in a single institution with a standardized protocol of investigation.

Authors:  Henning Feist; Simin Bajwa; Ulrich Pecks
Journal:  Arch Gynecol Obstet       Date:  2021-10-24       Impact factor: 2.493

3.  The PD-1/PD-L1 inhibitory pathway is altered in pre-eclampsia and regulates T cell responses in pre-eclamptic rats.

Authors:  Mei Tian; Yonghong Zhang; Zhaozhao Liu; Guoqiang Sun; Gil Mor; Aihua Liao
Journal:  Sci Rep       Date:  2016-06-09       Impact factor: 4.379

4.  Slow fetal growth between first and early second trimester ultrasound scans and risk of small for gestational age (SGA) birth.

Authors:  Marija Simic; Olof Stephansson; Gunnar Petersson; Sven Cnattingius; Anna-Karin Wikström
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

5.  Placental Peripartum Pathologies in Women with Preeclampsia and Eclampsia.

Authors:  Chijioke Ogomegbulam Ezeigwe; Charles Ikechukwu Okafor; George Uchenna Eleje; Gerald Okanandu Udigwe; Daniel Chukwuemeka Anyiam
Journal:  Obstet Gynecol Int       Date:  2018-09-20

6.  Clarification and confocal imaging of the nonhuman primate placental micro-anatomy.

Authors:  J A Sargent; Vhj Roberts; J E Gaffney; A E Frias
Journal:  Biotechniques       Date:  2018-10-29       Impact factor: 1.993

7.  Galectin-9 Alleviates LPS-Induced Preeclampsia-Like Impairment in Rats via Switching Decidual Macrophage Polarization to M2 Subtype.

Authors:  Zhi-Hui Li; Li-Ling Wang; Hong Liu; Kahinho P Muyayalo; Xiao-Bo Huang; Gil Mor; Ai-Hua Liao
Journal:  Front Immunol       Date:  2019-01-10       Impact factor: 7.561

8.  Glycemic control and fetal growth of women with diabetes mellitus and subsequent hypertensive disorders of pregnancy.

Authors:  Mamoru Morikawa; Emi Kato-Hirayama; Michinori Mayama; Yoshihiro Saito; Kinuko Nakagawa; Takeshi Umazume; Kentaro Chiba; Satoshi Kawaguchi; Kazuhiko Okuyama; Hidemichi Watari
Journal:  PLoS One       Date:  2020-03-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.